| risperidone / Generic mfg. |
NCT00249132: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia |
|
|
| Completed | 3 | 523 | US | risperidone | Janssen, LP | Schizophrenia, Psychotic Disorders | | 07/91 | | |
NCT00249119: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia |
|
|
| Completed | 3 | 1579 | US | risperidone | Janssen, LP | Schizophrenia, Psychotic Disorder | | 12/91 | | |
NCT00249145: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia |
|
|
| Completed | 3 | 349 | Europe | risperidone | Janssen Pharmaceutica N.V., Belgium | Dementia, Alzheimer Disease, Dementia, Vascular | | 12/96 | | |
NCT00253123: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia |
|
|
| Completed | 3 | 626 | US | risperidone | Janssen, LP | Dementia, Alzheimer Disease, Dementia, Vascular | | 03/97 | | |
NCT00266552: A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation |
|
|
| Completed | 3 | 118 | US, Europe | risperidone | Janssen Pharmaceutica N.V., Belgium | Conduct Disorder, Disruptive Behavior Disorder, Oppositional Defiant Disorder | | 10/98 | | |
NCT00253149: A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder |
|
|
| Completed | 3 | 158 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Bipolar Disorders, Manic Disorder | | 04/99 | | |
NCT00250354: A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation |
|
|
| Completed | 3 | 110 | US, Europe | Risperidone oral solution | Janssen Pharmaceutica N.V., Belgium | Conduct Disorder, Oppositional Defiant Disorder, Disruptive Behavior Disorder | | 08/99 | | |
NCT00250367: A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder. |
|
|
| Completed | 3 | 151 | US, Europe | risperidone | Janssen Pharmaceutica N.V., Belgium | Bipolar Disorder, Manic Disorder | | 11/99 | | |
NCT00249158: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia |
|
|
| Completed | 3 | 344 | RoW | Risperidone | Janssen-Cilag Pty Ltd | Dementia, Alzheimer Disease, Vascular Dementia | | 02/01 | | |
NCT00065273: Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay |
|
|
| Completed | 3 | 50 | US | risperidone, clozapine, olanzapine | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Mental Retardation, Developmental Delay Disorder | | 06/01 | | |
NCT00261508: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD) |
|
|
| Completed | 3 | 80 | US | risperidone | Janssen-Ortho Inc., Canada | DCild Development Disorders, Pervasive, Autistic Disorder, Developmental Disabilities, Asperger Syndrome, Rett Syndrome | | 12/01 | | |
NCT00249236: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder |
|
|
| Completed | 3 | 291 | US | Risperidone, oral tablets | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Bipolar Disorder, Manic Episode | | 12/01 | | |
NCT00257075: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder |
|
|
| Completed | 3 | 267 | US | Risperidone, oral tablets | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Bipolar Disorders, Manic Episode | | 05/02 | | |
NCT00253162: A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol |
|
|
| Completed | 3 | 439 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Bipolar Disorders, Manic Disorder | | 09/02 | | |
NCT00034762: Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease |
|
|
| Completed | 3 | 473 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Dementia, Alzheimer Disease, Mental Disorders | | 01/03 | | |
NCT00305422: Effect of Quetiapine on Negative Symptoms and Cognition |
|
|
| Completed | 3 | 45 | Europe | Quetiapine fumarate, Risperidone | AstraZeneca | Schizophrenia | | 01/03 | | |
NCT00287742: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease |
|
|
| Terminated | 3 | 33 | Japan | risperidone | Janssen Pharmaceutical K.K. | Alzheimer's Disease, Dementia | | 03/03 | | |
NCT00236444: A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders |
|
|
| Completed | 3 | 375 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Attention Deficit and Disruptive Behavior Disorders | | 09/03 | | |
NCT00645515: A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia |
|
|
| Terminated | 3 | 240 | Europe | Ziprasidone, Geodon, Zeldox, Risperidone | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Schizophrenia | | 12/03 | | |
NCT00236587: A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia |
|
|
| Completed | 3 | 100 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia | | 02/04 | | |
NCT00044681: A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression |
|
|
| Completed | 3 | 258 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen, LP | Depressive Disorder, Depressive Disorder, Major, Depression | | 03/04 | | |
NCT00297388: A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder |
|
|
| Completed | 3 | 40 | US | Risperidone, long-acting injectable | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen, LP | Schizophrenia, Schizoaffective Disorder | | 09/04 | | |
NCT00159770: Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients |
|
|
| Completed | 3 | 290 | Europe, RoW | ziprasidone versus olanzapine , risperidone or quetiapine, Panss , CGI-C, UKU-SERS-Pa, Blood tests | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Schizophrenia, Schizoaffective Disorder, Psychotic Disorders | | 09/04 | | |
NCT00161018: New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia |
|
|
| Completed | 3 | 150 | US | Quetiapine, Risperidone, Fluphenazine | University of Maryland, Baltimore | Schizophrenia | 11/04 | 11/04 | | |
NCT00283179: Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia |
|
|
| Completed | 3 | 83 | RoW | Aripiprazole, Risperidone | Taiwan Otsuka Pharm. Co., Ltd | Schizophrenia, Schizoaffective Disorder | | 12/04 | | |
NCT00174577: Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant |
|
|
| Unknown status | 3 | 84 | US | Risperidone | Rhode Island Hospital, Janssen Pharmaceutica N.V., Belgium, Emory University | Major Depression | | 02/05 | | |
NCT00034892: CAFE Comparison of Atypicals in First Episode of Psychosis |
|
|
| Completed | 3 | | US, Canada | Olanzapine, risperidone | AstraZeneca, University of North Carolina | Schizophrenia, Psychotic Disorders, Mental Health, Mental Disorders | 03/05 | 03/05 | | |
NCT00179244: Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression |
|
|
| Completed | 3 | 30 | US | Rispridone (drug) and Bupropion ER (drug) | Vanderbilt University, Janssen Pharmaceutica | Unipolar Depression | | 04/05 | | |
NCT00645372: A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients |
|
|
| Completed | 3 | 242 | RoW | Risperidone, Ziprasidone | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Schizophrenia | | 05/05 | | |
NCT00097032: Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients |
|
|
| Completed | 3 | 30 | US | risperidone; quetiapine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen, LP | Bipolar Disorder | | 05/05 | | |
NCT00086112: Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy. |
|
|
| Completed | 3 | 301 | US | risperidone oral tablets | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen, LP | Anxiety Disorders | | 06/05 | | |
NCT00399698: Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. |
|
|
| Completed | 3 | 30 | US | Risperdal | Ohio State University | Oppositional Defiant Disorder, Conduct Disorder, Attention Deficit/Hyperactivity Disorder (ADHD), Intermittent Explosive Disorder, Impulse-Control Disorders, Adjustment Disorder, Bipolar Disorder, Pervasive Developmental Disorder | | 06/05 | | |
| Completed | 3 | 700 | Europe | Aripiprazole, Abilify, Olanzapine or Quetiapine or Risperidone | Otsuka Pharmaceutical Development & Commercialization, Inc., Otsuka America Pharmaceutical | Schizophrenia | 08/05 | 08/05 | | |
NCT00095134: Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy |
|
|
| Completed | 3 | 630 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen, LP | Major Depressive Disorder | | 11/05 | | |
NCT00076115: Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents |
|
|
| Completed | 3 | 13 | US | Risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Bipolar Disorder | | 12/05 | | |
NCT00088075: Investigate Risperidone for the Treatment of Schizophrenia in Adolescents |
|
|
| Completed | 3 | 160 | US | Risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia | | 12/05 | | |
NCT00034749: The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia |
|
|
| Completed | 3 | 279 | US | Risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia | | 03/06 | | |
NCT00246246: A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder |
|
|
| Completed | 3 | 48 | US | risperidone | Janssen-Ortho Inc., Canada | Bipolar Disorder | | 04/06 | | |
NCT00240708: A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia |
|
|
| Completed | 3 | 205 | Japan | risperidone | Janssen Pharmaceutical K.K. | Schizophrenia | | 04/06 | | |
NCT00246272: An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone |
|
|
| Completed | 3 | 82 | US | risperidone | Janssen-Ortho Inc., Canada | Schizophrenia | | 05/06 | | |
NCT00246285: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia |
|
|
| Completed | 3 | 381 | US | risperidone | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia, Psychotic Disorders | | 12/06 | | |
NCT00216580: A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis |
|
|
| Completed | 3 | 50 | Europe | Risperidone, long-acting injectable | Janssen Pharmaceutica N.V., Belgium | Schizophrenia | | 12/06 | | |
NCT00843687: A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients. |
|
|
| Completed | 3 | 188 | US | Risperidone long-acting injectable | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Schizophrenia | 03/07 | 03/07 | | |
NCT00167154: Risperidone and Suicidality in Major Depressive Disorder |
|
|
| Completed | 3 | 30 | US | Risperidone and placebo comparator | University of Alabama at Birmingham, Janssen Pharmaceuticals | Depression | 04/07 | 08/08 | | |
NCT01888107 / 2004-000830-35: Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder |
|
|
| Completed | 3 | 347 | Europe | Risperidone Long-acting Injectable (LAI) 25 mg, Risperidone LAI 37.5 mg, Risperidone LAI 50 mg | Janssen-Cilag S.p.A. | Schizophrenia, Schizoaffective Disorder | 04/07 | 04/07 | | |
NCT00174590: Treatment of Major Depressive Disorder With Psychotic Features. |
|
|
| Terminated | 3 | 30 | US | risperidone | Rush University Medical Center, Janssen, LP | Major Depression With Psychotic Features | | 08/07 | | |
NCT00176202: Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar |
|
|
| Completed | 3 | 65 | US | Divalproex Sodium, antiepileptic, valproic acid, risperidone, antipsychotic, risperdal | University of Illinois at Chicago | Bipolar Disorder | 01/08 | 01/08 | | |
| Completed | 3 | 9809 | Europe, RoW | Sertindole, Serdolect, Risperidone, Risperdal | H. Lundbeck A/S | Schizophrenia | 02/08 | 02/08 | | |
| Completed | 3 | 286 | US, Canada, Europe, RoW | Aripiprazole, Olanzapine, Risperidone, Quetiapine, Ziprasidone | Solvay Pharmaceuticals, H. Lundbeck A/S, Wyeth is now a wholly owned subsidiary of Pfizer | Schizophrenia and Schizoaffective Disorder | 02/08 | 02/08 | | |
NCT00366704: Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint |
|
|
| Terminated | 3 | 400 | US | bifeprunox, risperidone | Wyeth is now a wholly owned subsidiary of Pfizer, Solvay Pharmaceuticals | Schizophrenia | 03/08 | 03/08 | | |
| Unknown status | 3 | 20 | Europe | Bromocriptin | University Hospital, Bonn | Schizophrenia, Hyperprolactinemia | | 05/08 | | |
2008-001015-38: A randomized, placebo-controlled study of the central cannabinoid (CB1) receptor antagonist rimonabant as adjunctive therapy to improve cognition in schizophrenia |
|
|
| Ongoing | 3 | 70 | Europe | Risperidone, Rimonabant, Film-coated tablet, Risperidone, Rimonabant | LWL University Hospital Bochum, Ruhr-University Bochum | Schizophrenia | | | | |
TEAM, NCT00057681: Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents |
|
|
| Completed | 3 | 379 | US | Lithium carbonate, Valproate, Depakote, Risperidone, Risperdal | Washington University School of Medicine, National Institute of Mental Health (NIMH) | Bipolar Disorder | 12/08 | 12/08 | | |
| Terminated | 3 | 29 | Europe | Quetiapine, Seroquel, Risperidone, Risperdal | AstraZeneca | Schizophrenic Disorders | 12/08 | 12/08 | | |
NCT00604279: A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia |
|
|
| Completed | 3 | 452 | RoW | Paliperidone palmitate (R092670), Risperidone | Xian-Janssen Pharmaceutical Ltd. | Schizophrenia | 01/09 | 01/09 | | |
NCT00277654: Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder |
|
|
| Completed | 3 | 111 | US | Risperidone, Risperidal | Lindner Center of HOPE, Janssen Pharmaceuticals, University of Cincinnati | Bipolar Disorder, Anxiety Disorder | 03/09 | 03/09 | | |
NCT00391222: A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder |
|
|
| Completed | 3 | 585 | Europe, RoW | Olanzapine, Placebo, Risperidone Long Acting Injectable (LAI) | Janssen Pharmaceutica N.V., Belgium | Bipolar Disorder | 04/09 | 04/09 | | |
NCT00132314: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia |
|
|
| Completed | 3 | 382 | US | IM risperidone, oral antipsychotic medication | US Department of Veterans Affairs | Schizoaffective Disorder, Schizophrenia | 09/09 | 09/09 | | |
RECOVER, NCT00600756: Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone |
|
|
| Completed | 3 | 798 | Europe, RoW | Quetiapine XR, Seroquel XR, Risperidone, Risperdal | AstraZeneca | Schizophrenic Disorders | 10/09 | 10/09 | | |
| Completed | 3 | 216 | Europe | Quetiapine Extended Release, Seroquel XR™, Risperidone, Risperdal | AstraZeneca | Schizophrenia, Depression | 02/10 | 02/10 | | |
NCT00857818: Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome |
|
|
| Terminated | 3 | 64 | Canada | Aripiprazole, Abilify, BMS-334039, Oanzapine, risperidone, or quetiapine | Otsuka Pharmaceutical Development & Commercialization, Inc. | Schizophrenia, Schizoaffective Disorder, Bipolar I Disorder, Metabolic Syndrome | 03/10 | 03/10 | | |
NCT00711269: Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia |
|
|
| Completed | 3 | 460 | Japan, RoW | SM-13496 (lurasidone HCl), Placebo, Risperidone | Sumitomo Pharma Co., Ltd. | Schizophrenia | 04/10 | 04/10 | | |
|
NCT02456454: Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder |
|
|
| Completed | 3 | 46 | NA | Risperidone, Risperdal, Valproic Acid, Valproate, Placebo | Nationwide Children's Hospital, Stanley Medical Research Institute | Bipolar Disorder | 06/10 | 06/10 | | |
NCT00641745: Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia |
|
|
| Completed | 3 | 629 | US, RoW | Lurasidone HCl, Risperidone | Sunovion | Schizophrenia, Schizoaffective Disorder | 07/10 | 07/10 | | |
|
NCT00435370: Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia |
|
|
| Completed | 3 | 179 | US, RoW | Tropisetron, Navoban, Placebo, Risperidone, Risperdal, Ridal, Rispolept | Baylor College of Medicine, National Institute of Mental Health (NIMH) | Smoking Cessation, Schizophrenia | 02/11 | 08/11 | | |
NCT01391403: Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia |
|
|
| Completed | 3 | 88 | RoW | Artemisinin, Qinghaosu, Placebo | Beijing HuiLongGuan Hospital, Stanley Medical Research Institute | Schizophrenia | 04/11 | 05/11 | | |
NCT00221403: Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders |
|
|
| Completed | 3 | 46 | US | Risperidone oral solution, Risperdal, Valproate Oral Solution, VPA, Placebo | Children's Hospital Medical Center, Cincinnati, Stanley Medical Research Institute | Bipolar Disorder | 05/11 | 05/11 | | |
NCT01977300: Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode |
|
|
| Completed | 3 | 159 | Canada | Valproate, Valproic Acid, Lithium, Lithium Carbonate, Risperidone, Risperdal, Olanzapine, Zyprexa, Placebo, Sugar Pill | University of British Columbia, Canadian Institutes of Health Research (CIHR), Eli Lilly and Company, Janssen-Ortho Inc., Canada | Bipolar I Disorder | 08/11 | 08/11 | | |
| Completed | 3 | 160 | Europe | Zicronapine, Past name: Lu 31-130, Risperidone, Risperdal® | H. Lundbeck A/S | Schizophrenia | 10/12 | | | |
NCT01370291: Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients |
|
|
| Unknown status | 3 | 60 | RoW | active Risperidone and active rTMS, Risperidone:Xian-Janssen pharmaceutical ltd, rTMS:MagVenture, active rTMS and sham Risperidone, rTMS: MagVenture, sham rTMS and active Risperidone | Xijing Hospital | Schizophrenia | 12/12 | 12/13 | | |
NCT01516424: Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone |
|
|
| Completed | 3 | 267 | RoW | Blonanserin, Lonasen, Risperidone, Risperdal | Sumitomo Pharma (Suzhou) Co., Ltd. | Schizophrenia | 02/13 | 02/13 | | |
ACTRN12607000562471: Oral risperidone, oral haloperidol, and oral placebo in the management of delirium in palliative care. |
|
|
| Completed | 3 | 165 | | | Flinders University, Commonwealth Department of Health and Ageing | delirium | | | | |
NCT02002832: A Clinical Trial of Lurasidone in Treatment of Schizophrenia |
|
|
| Completed | 3 | 388 | RoW | Lurasidone tablets, LATUDA, Risperidone tablets | Sumitomo Pharma (Suzhou) Co., Ltd. | Schizophrenia | 04/15 | 11/15 | | |
NCT02453893: Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia |
|
|
| Unknown status | 3 | 288 | RoW | Iloperidone, Risperidone | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Schizophrenia | 06/15 | | | |
NCT01765829 / 2011-004826-87: Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis |
|
|
| Unknown status | 3 | 104 | Europe | Discontinuation antipsychotic treatment, Aripiprazole, Olanzapine, Zuclopenthixol, Clotiapine, Flupentixol, Risperidone, Sulpiride, Trifluoperazine, Haloperidol, Quetiapine, Paliperidone, Chlorpromazine, Pipotiazine, Flufenazine, Periciazine, Clozapine, Pimozide, Perfenazine, Sertindole, Levomepromazine, Amisulpride, Asenapine, Tiapride, Droperidol, Ziprasidone, Antipsychotic treatment, Antipsychotic drugs | Fundación Pública Andaluza Progreso y Salud, Instituto de Salud Carlos III | Psychosis Nos/Other | 11/15 | 11/15 | | |
2005-002979-33: Estudio de la eficacia y seguridad de risperidona en el tratamiento de adolescentes con esquizofrenia: Estudio abierto de seis meses. |
|
|
| Ongoing | 3 | 8 | Europe | Risperdal 1mg, F5, Risperdal1 mg, Risperdal1 mg | Janssen-Cilag International N.V. | SCHIZOPHRENIA/ Adolescents | | | | |
2008-003623-23: Effect of different antipsychotic medication on craving related brain activity in patients with schizophrenia and cannabis abuse or dependence:a randomized controlled study comparing clozapine and risperidone. |
|
|
| Ongoing | 3 | 70 | Europe | Clozapine, Risperidone, | Academisch medisch centrum, department of psychiatry | A randomized controlled trial comparing the effect of clozapine and risperidone on cannabis craving in cannabis abusing or dependent patients with schizophrenia. Specific cognitive tasks will be used to test craving pathways and associated brain activities are assessed with functional MRI. | | | | |
2008-000243-33: Alzheimer disease and antipsycotics: a long term multicenter randomized clinical trial |
|
|
| | 3 | 1000 | Europe | Risperidone, Olanzapine, Quetiapine, Haloperidol, | ISTITUTO SUPERIORE DI SANITA\' | BPSD in Alzheimer disease | | | | |
2008-007800-27: A Prospective, Randomized, Active-controlled, Rater-blinded Study of thePrevention of Relapse Comparing Paliperidone Palmitate with Oral Risperidone inAdults with Recently-Diagnosed Schizophrenia Who Are at High Risk of Relapse |
|
|
| | 3 | 48 | Europe | Palperidone palmitate, Risperidone - film-coated tablet - 1 mg, Risperidone - film-coated tablet - 2 mg, Risperidone - film-coated tablet - 4 mg, R092670 (F013), R064766 (F05), R064766, RISPERDAL, RISPERDAL | Janssen-Cilag International NV | Recently-Diagnosed Schizophrenia | | 02/10 | | |
2009-011594-33: A randomized, double-blind, placebo-controlled study of tetrabenazine as adjunctive therapy to risperidone in first-episode schizophrenia |
|
|
| Ongoing | 3 | 60 | Europe | Risperidone, Tetrabenazine, Risperdal, Risperdal | LWL University Hospital Bochum, Ruhr-University Bochum | Schizophrenia | | | | |
| | 3 | 14 | Europe | Pomaglumetad methionil, ABILIFY, ZYPREXA, RISPERDAL, SEROQUEL, LY2140023, 129722-12-9, | Eli Lilly and Company, Lilly S.A., Eli Lilly and Company, , Lilly S.A. | Schizophrenia | | 08/12 | | |
2012-005485-36: A Randomized, Double-blind, Parallel-group Study to Investigate the Efficacy, Safety and Tolerability of Cariprazine in Patients with Predominant Negative Symptoms of Schizophrenia |
|
|
| Completed | 3 | 50 | Europe | Cariprazine, Risperdal, Risperdal, Risperdal | Gedeon Richter Plc, Gedeon Richter Plc | Patients with Predominant Negative Symptoms of Schizophrenia | | 11/14 | | |
|
| Withdrawn | 3 | 0 | US | brexpiprazole, Rexulti (R), risperidone | H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. | Schizophrenia | 06/16 | | | |
NCT02469155: A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment |
|
|
| Completed | 3 | 696 | US | ITI-007, Risperidone, Placebo | Intra-Cellular Therapies, Inc. | Schizophrenia | 08/16 | 08/16 | | |
|
|
|
2014-003834-21: Effectiveness of penfluridol (oral long acting neuroleptic) as compared to second generation oral neuroleptics in psychotic disorder patients: an open label randomized controlled trial. Effectiviteit van penfluridol (oraal lang-werkend neurolepticum) in vergelijking met orale tweede-generatie antispychotica in patienten met een psychotische stoornis: een open label randomized controlled trial. |
|
|
| Terminated | 3 | 180 | Europe | olanzapine, risperdal, penfluridol, Coated tablet, Tablet, Zyprexa, risperidon | Erasmus Medical Center Rotterdam, ZonMw | Psychotic disorders Psychotische stoornissen, Psychotic disorder Psychotische stoornissen, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2013-004881-33: Multicentre trial in to investigate the usage of antidepressant and antipsychotics (with / without approval) in patients at the age of children and adolescents Groß an gelegte, einfache offene klinische Studie mit mehreren teilnehmenden Prüfzentren zur Anwendung von Antidepressiva und Neuroleptika (mit /ohne Zulassung) |
|
|
| Ongoing | 3 | 1000 | Europe | Tablet, Abilify, Zyprexa, Leponex, Seroquel, Risperdal, Zeldox, Melneurin, Dipiperon, Saroten, Cipramil, Anafranil, Aponal, Cymbalta, Cipralex, Fluctin, Fevarin, Tofranil, Ludiomil, Remergil, Nortrilen, Paroxat, Zoloft, Stangyl, Trevilor | Universitätsklinikum Würzburg, Kompetenznetz TDM-KJP e.V., BfArM | therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT02374567: Pharmacovigilance in Gerontopsychiatric Patients |
|
|
| Terminated | 3 | 407 | Europe | Phenobarbital, Phenytoin, Carbamazepine, Oxcarbazepine, Valproic Acid, Lamotrigine, Topiramate, Gabapentin, Levetiracetam, Pregabalin, Lacosamide, Clonazepam, Biperiden, Levomepromazine, Fluphenazine, Perphenazine, Perazine, Thioridazine, Haloperidol, Melperone, Pipamperone, Bromperidol, Benperidol, Sertindole, Ziprasidone, Flupentixol, Chlorprothixene, Zuclopenthixol, Fluspirilene, Pimozide, Clozapine, Olanzapine, Quetiapine, Sulpiride, Tiapride, Amisulpride, Prothipendyl, Risperidone, Aripiprazole, Paliperidone, Diazepam, Oxazepam, Lorazepam, Bromazepam, Clobazam, Alprazolam, Hydroxyzine, Buspirone, Chloral Hydrate, Flurazepam, Nitrazepam, Triazolam, Lormetazepam, Temazepam, Midazolam, Brotizolam, Zopiclone, Zolpidem, Zaleplon, Melatonin, Clomethiazole, Diphenhydramine, Promethazine, Imipramine, Clomipramine, Opipramol, Trimipramine, Amitriptyline, Nortriptyline, Doxepin, Maprotiline, Amitriptyline oxide, Fluoxetine, Citalopram, Paroxetine, Sertraline, Fluvoxamine, Escitalopram, Tranylcypromine, Moclobemide, Mianserin, Trazodone, Mirtazapine, Bupropion, Venlafaxine, Reboxetine, Duloxetine, Agomelatine, Pyritinol, Piracetam, Donepezil, Rivastigmine, Galantamine, Memantine, Nicergoline, Acamprosate, Lithium | Hannover Medical School | Dementia, Depression, Schizophrenia, Psychosomatic Disorders, Anxiety Disorders | 06/17 | 06/17 | | |
2016-002859-19: Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail? Antipsychotica afbouwen bij mensen met een verstandelijke beperking: waarom lukt het niet? |
|
|
| Ongoing | 3 | 126 | Europe | Risperidone, Pipamperone, Oral liquid, Risperidone, Pipamperone | Erasmus MC, Abrona, Ipse de Bruggen, Amarant | People with challenging behavior and off-label antipsychotic use Mensen met een verstandelijke beperking en gedragsproblemen waarvoor offlabel antipsychotica gebruik, People with challenging behavior and off-label antipsychotic use Mensen met een verstandelijke beperking en gedragsproblemen waarvoor offlabel antipsychotica gebruik, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT02773576: Safety and Tolerability of Risperidone Implants |
|
|
| Completed | 3 | 140 | US | Risperidone implant | Braeburn Pharmaceuticals | Schizophrenia | 09/17 | 09/17 | | |
| Completed | 3 | 1098 | Europe, Canada, US, RoW | Risperidone, Olanzapine, Lu AF35700 | H. Lundbeck A/S | Schizophrenia | 08/18 | 10/18 | | |
| Terminated | 3 | 119 | Europe, Japan, US, RoW | Lu AF35700, Risperidone, Olanzapine | H. Lundbeck A/S | Treatment-resistant Schizophrenia | 12/18 | 02/19 | | |
DREaM, NCT02431702: A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform |
|
|
| Completed | 3 | 337 | US, RoW | Aripiprazole, Haloperidol, Olanzapine, Oral Paliperidone ER, Perphenazine, Quetiapine, Oral Risperidone, Paliperidone Palmitate Injection (PP1M), Paliperidone Palmitate Injection (PP3M) | Janssen Scientific Affairs, LLC | Schizophrenia, Psychotic Disorders | 11/19 | 11/19 | | |
NCT05779241: Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005 |
|
|
| Completed | 3 | 83 | US | LYN-005, Risperidone, Risperdal | Lyndra Inc. | Schizophrenia, Schizoaffective Disorder | 11/23 | 12/23 | | |
NCT00235352: Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia |
|
|
| Completed | 2/3 | 105 | US | CX516 (Ampakine) | North Suffolk Mental Health Association, RespireRx | Schizophrenia | 04/05 | 02/07 | | |
NCT00063349: Clozapine and Risperidone for Treatment of First Episode Schizophrenia and Cannabis Use Disorder |
|
|
| Suspended | 2/3 | 38 | US | Risperidone, Clozapine | National Institute of Mental Health (NIMH) | Schizophrenia, Marijuana Abuse | | | | |
| Completed | 2/3 | 80 | US | sertraline and risperidone | Duke University, Janssen Pharmaceuticals | Post-Traumatic Stress Disorder | | 07/06 | | |
| Completed | 2/3 | 161 | RoW | Dextromethorphan | National Cheng-Kung University Hospital | Schizophrenia | 12/08 | 12/08 | | |
| Withdrawn | 2/3 | 0 | US | Aripiprazole, Zyprexa, Risperdal | Washington University School of Medicine, Pfizer | Diabetes | 11/09 | 11/09 | | |
| Terminated | 2/3 | 1210 | Japan, US, RoW | LY2140023, mGlu 2/3 Prodrug II, Olanzapine, Zyprexa, LY170053, Aripiprazole, Risperidone, Quetiapine | Eli Lilly and Company | Schizophrenia | 10/12 | 10/12 | | |
NCT01625897: A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia |
|
|
| Completed | 2/3 | 125 | Japan | MP-214, Risperidone | Mitsubishi Tanabe Pharma Corporation | Schizophrenia | 03/15 | 03/15 | | |
